A large randomized controlled trial of a pneumococcal conjugate vaccine in South Africa found that use of the vaccine prevented 10 times as many cases of pneumococcal pneumonia in HIV positive children than in HIV negative children.
Full Citation:
Madhi, S.A., Kuwanda, L., Cutland, C., et al.. 2005. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clinical Infectious Disease. 40(10).
Title of Article: The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children
Author(s): Madhi, S.A., Kuwanda, L., Cutland, C., et al.
Publication Year: 2005
Publication Name: Clinical Infectious Disease
Publication Volume: 40(10)
Publication Source URL: https://academic.oup.com/cid/article-lookup/doi/10.1086/429828
DOI (Digital Object Identifier): 10.1086/429828
Topics: Health
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Immunization Terms: HIV
Countries: South Africa
WHO Regions: Africa